Luminai Raises $38M Series B to Scale AI-Powered Healthcare Automation

Team S · 2026-04-11T14:10:41.000Z

San Francisco-based AI startup Luminai has raised $38 million in a Series B funding round, highlighting growing investor confidence in AI-driven enterprise automation for complex healthcare operations. The round was led by Peak XV Partners, with participation from Define Ventures, General Catalyst, and Y Combinator, reflecting strong backing from global investors focused on scaling applied AI solutions in high-impact industries. Founded in 2020, Luminai develops AI-powered robotic process automation software designed to handle repetitive and multi-step workflows across enterprise systems. Its platform simulates human actions across digital interfaces, enabling organizations to streamline operations in sectors such as healthcare, finance, and customer service. What differentiates Luminai is its ability to combine healthcare-trained AI models with a configurable workflow engine and human-in-the-loop validation, ensuring accuracy and reliability in highly regulated environments. The platform is built to manage fragmented and unstructured data, transforming it into actionable intelligence that powers end-to-end automation. As healthcare systems worldwide face increasing administrative complexity and operational inefficiencies, solutions like Luminai are emerging as critical infrastructure. The company is already working with major healthcare providers to automate high-volume workflows, improving efficiency and reducing manual burden across operations. The newly raised capital will be used to expand product capabilities, grow engineering and deployment teams, and support rising enterprise demand for scalable AI automation solutions. With total funding now reaching $60 million, Luminai is positioning itself as a key player in the transformation of healthcare operations through AI.

Member Login Get Access

Luminai Raises $38M Series B to Scale AI-Powered Healthcare Automation | Newnex